Drug name - Olux E

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8962000 MYLAN Microemulsion and sub-micron emulsion process and compositions Aug, 2025

(2 years from now)

US8460641 MYLAN Microemulsion process and composition Nov, 2028

(6 years from now)

Drugs and Companies using CLOBETASOL PROPIONATE ingredient

Treatment: Treatment of corticosteroid-responsive dermatoses


More Information on Dosage
Strength Dosage Availability
0.05% AEROSOL, FOAM;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.